-
This report begins with discussion of the most superficial lesions and progresses through the skin and soft tissue to the deeper and systemic disease processes.
-
A return to full normal activities, including work at 2 weeks, after AMI appears to be safe in patients who are stratified to a low-risk group.
-
The number of previous acute exacerbations of chronic bronchitis (AECBs) and the baseline FEV1 level are potent prognostic factors of the short- and long-term outcomes of AECB.
-
Itopride, a D2 dopamine agonist with anticholinesterase effects, was marginally superior to placebo in 'functional dyspepsia.'
-
Visual hallucinations, extrapyramidal motor signs, and visuoconstructional impairments at time of presentation are strongly suggestive of a diagnosis of dementia with Lewy bodies.
-
A novel T-cell inhibitor has been approved for the treatment of rheumatoid arthritis. Abatacept is the first selective modulator of a costimulatory signal involved in T-cell activation (costimulatory blocker).
-
-
-
As biomedical technology progresses, the medical practitioner is presented with rapidly changing multiple options to diagnose acute disease states.
-
